BP Lipid 556 is a novel hybrid of TCL053 and IAJD93 ionizable lipids. The key feature is the introduction of monounsaturated ether lipids derived from oleic acid. The ionizable head group consists of a heterocyclic 3-pyrrolidinepropanoate biodegradable ester. This compound may be used in lipid nanoparticle (LNP) formulations for drug or mRNA delivery applications.
Usually ships within 24 hours.